SOTERA HEALTH CO (SHC) Stock Price & Overview

NASDAQ:SHCUS83601L1026

Current stock price

15.82 USD
+0.12 (+0.76%)
Last:

The current stock price of SHC is 15.82 USD. Today SHC is up by 0.76%. In the past month the price increased by 17.03%. In the past year, price increased by 49.81%.

SHC Key Statistics

52-Week Range10.17 - 19.85
Current SHC stock price positioned within its 52-week range.
1-Month Range13.09 - 15.74
Current SHC stock price positioned within its 1-month range.
Market Cap
4.499B
P/E
18.40
Fwd P/E
16.26
EPS (TTM)
0.86
Dividend Yield
N/A

SHC Stock Performance

Today
+0.76%
1 Week
+5.58%
1 Month
+17.03%
3 Months
-18.14%
Longer-term
6 Months -2.85%
1 Year +49.81%
2 Years +40.18%
3 Years -6.38%
5 Years -39.05%
10 Years N/A

SHC Stock Chart

SOTERA HEALTH CO / SHC Daily stock chart

SHC Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to SHC. When comparing the yearly performance of all stocks, SHC turns out to be only a medium performer in the overall market: it outperformed 68.61% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

SHC Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to SHC. SHC has an excellent profitability rating, but there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SHC Earnings

On February 24, 2026 SHC reported an EPS of 0.26 and a revenue of 303.44M. The company beat EPS expectations (6.15% surprise) and beat revenue expectations (0.31% surprise).

Next Earnings DateApr 30, 2026
Last Earnings DateFeb 24, 2026
PeriodQ4 / 2025
EPS Reported$0.26
Revenue Reported303.441M
EPS Surprise 6.15%
Revenue Surprise 0.31%

SHC Forecast & Estimates

15 analysts have analysed SHC and the average price target is 21.17 USD. This implies a price increase of 33.79% is expected in the next year compared to the current price of 15.82.

For the next year, analysts expect an EPS growth of 13.17% and a revenue growth 6.83% for SHC


Analysts
Analysts84
Price Target21.17 (33.82%)
EPS Next Y13.17%
Revenue Next Year6.83%

SHC Groups

Sector & Classification

SHC Financial Highlights

Over the last trailing twelve months SHC reported a non-GAAP Earnings per Share(EPS) of 0.86. The EPS increased by 22.86% compared to the year before.


Income Statements
Revenue(TTM)1.16B
Net Income(TTM)77.95M
Industry RankSector Rank
PM (TTM) 6.7%
ROA 2.39%
ROE 12.86%
Debt/Equity 3.66
Chartmill High Growth Momentum
EPS Q2Q%23.81%
Sales Q2Q%4.56%
EPS 1Y (TTM)22.86%
Revenue 1Y (TTM)-13.72%

SHC Ownership

Ownership
Inst Owners74.36%
Shares284.39M
Float245.76M
Ins Owners2.31%
Short Float %4.93%
Short Ratio4.37

About SHC

Company Profile

SHC logo image Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. The company is headquartered in Broadview Heights, Ohio and currently employs 3,000 full-time employees. The company went IPO on 2020-11-20. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

Company Info

IPO: 2020-11-20

SOTERA HEALTH CO

9100 South Hills Blvd, Suite 300, Suite 300

Broadview Heights OHIO 44147 US

CEO: Michael B. Petras

Employees: 3000

SHC Company Website

SHC Investor Relations

Phone: 14402621410

SOTERA HEALTH CO / SHC FAQ

What does SHC do?

Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. The company is headquartered in Broadview Heights, Ohio and currently employs 3,000 full-time employees. The company went IPO on 2020-11-20. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.


What is the stock price of SOTERA HEALTH CO today?

The current stock price of SHC is 15.82 USD. The price increased by 0.76% in the last trading session.


What is the dividend status of SOTERA HEALTH CO?

SHC does not pay a dividend.


What is the ChartMill technical and fundamental rating of SHC stock?

SHC has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


How is the market expecting SHC stock to perform?

15 analysts have analysed SHC and the average price target is 21.17 USD. This implies a price increase of 33.79% is expected in the next year compared to the current price of 15.82.


What is the expected growth for SHC stock?

The Revenue of SOTERA HEALTH CO (SHC) is expected to grow by 6.83% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.